Literature DB >> 22077218

Alternative therapies for Helicobacter pylori: probiotics and phytomedicine.

Jorge M B Vítor1, Filipa F Vale.   

Abstract

Helicobacter pylori is a common human pathogen infecting about 30% of children and 60% of adults worldwide and is responsible for diseases such as gastritis, peptic ulcer and gastric cancer. Treatment against H. pylori is based on the use of antibiotics, but therapy failure can be higher than 20% and is essentially due to an increase in the prevalence of antibiotic-resistant bacteria, which has led to the search for alternative therapies. In this review, we discuss alternative therapies for H. pylori, mainly phytotherapy and probiotics. Probiotics are live organisms or produced substances that are orally administrated, usually in addition to conventional antibiotic therapy. They may modulate the human microbiota and promote health, prevent antibiotic side effects, stimulate the immune response and directly compete with pathogenic bacteria. Phytomedicine consists of the use of plant extracts as medicines or health-promoting agents, but in most cases the molecular mode of action of the active ingredients of these herbal extracts is unknown. Possible mechanisms include inhibition of H. pylori urease enzyme, disruption of bacterial cell membrane, and modulation of the host immune system. Other alternative therapies are also reviewed.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22077218     DOI: 10.1111/j.1574-695X.2011.00865.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  37 in total

Review 1.  Nontraditional therapies to treat Helicobacter pylori infection.

Authors:  Morris O Makobongo; Jeremy J Gilbreath; D Scott Merrell
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Authors:  Rodolfo Villarreal-Calderon; Arturo Luévano-González; Mariana Aragón-Flores; Hongtu Zhu; Ying Yuan; Qun Xiang; Benjamin Yan; Kathryn Anne Stoll; Janet V Cross; Kenneth A Iczkowski; Alexander Craig Mackinnon
Journal:  Ann Diagn Pathol       Date:  2014-02-11       Impact factor: 2.090

Review 3.  Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.

Authors:  Javier Molina-Infante; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 4.  Use of probiotics in the fight against Helicobacter pylori.

Authors:  Paolo Ruggiero
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

5.  Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection.

Authors:  Jin-Eung Kim; Min-Soo Kim; Yeo-Sang Yoon; Myung-Jun Chung; Do-Young Yum
Journal:  J Microbiol       Date:  2014-10-03       Impact factor: 3.422

6.  Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials.

Authors:  Yi Gong; Yan Li; Qian Sun
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis.

Authors:  Hong-Jing Yu; Wei Liu; Zhen Chang; Hui Shen; Li-Juan He; Sha-Sha Wang; Lu Liu; Yuan-Ying Jiang; Guo-Tong Xu; Mao-Mao An; Jun-Dong Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 8.  Role of dietary polyphenols in the management of peptic ulcer.

Authors:  Mohammad Hosein Farzaei; Mohammad Abdollahi; Roja Rahimi
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 9.  Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.

Authors:  Simona Di Caro; Lucia Fini; Yayha Daoud; Fabio Grizzi; Antonio Gasbarrini; Antonino De Lorenzo; Laura Di Renzo; Sara McCartney; Stuart Bloom
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

10.  Influence of inhomogeneous static magnetic field-exposure on patients with erosive gastritis: a randomized, self- and placebo-controlled, double-blind, single centre, pilot study.

Authors:  Márk Juhász; Viktor L Nagy; Hajnal Székely; Dorottya Kocsis; Zsolt Tulassay; János F László
Journal:  J R Soc Interface       Date:  2014-09-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.